FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: GENERIC DRUG USER FEES; CONSULTATION MEETINGS ON REAUTHORIZATION OF GENERIC DRUG USER FEE AMENDMENTS FOR FISCAL YEARS 2028-2032; REQUEST FOR NOTIFICATION OF INTENTION TO PARTICIPATE

WASHINGTON, June 26 -- Food and Drug Administration has issued a notice called: Generic Drug User Fees; Consultation Meetings on Reauthorization of Generic Drug User Fee Amendments for Fiscal Years 2028-2032; Request for Notification of Intention to Participate.

The notice was published in the Federal Register on June 26 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.

Summary: The Food and Drug Administration (FDA or Agency) is issuing this notice to request that interested parties, including patient and consumer advocacy groups, health care professionals, and scientific and academic experts notify FDA of their intent to participate in periodic consultation meetings on the reauthorization of the...